Conjunctival tumor
diseaseOn this page
Also known as conjunctiva neoplasmconjunctiva neoplasm (disease)conjunctiva tumorconjunctiva tumourconjunctival neoplasmconjunctival neoplasmsneoplasm of conjunctivaneoplasm of the conjunctivatumor of conjunctivatumor of the conjunctivatumour of conjunctivatumour of the conjunctiva
Summary
Conjunctival tumor (MONDO:0020204) is a cancer and 3 clinical trials. Top therapeutic interventions include ranibizumab. A subtype of conjunctival disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Classification: Cancer
- Clinical trials: 3
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | conjunctival tumor |
| Mondo ID | MONDO:0020204 |
| Orphanet | 98616 |
| NCIT | C2961 |
| UMLS | C0009761 |
| MedGen | 3208 |
| Anatomy (UBERON) | UBERON:0001811 |
| Is cancer (heuristic) | yes |
Also known as: conjunctiva neoplasm · conjunctiva neoplasm (disease) · conjunctiva tumor · conjunctiva tumour · conjunctival neoplasm · conjunctival neoplasms · conjunctival tumor · neoplasm of conjunctiva · neoplasm of the conjunctiva · tumor of conjunctiva · tumor of the conjunctiva · tumour of conjunctiva · tumour of the conjunctiva
Disease family
This is a subtype of conjunctival disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › disorder of orbital region › eye adnexa disorder › conjunctival disorder › conjunctival tumor
Related subtypes (7): conjunctival degeneration, conjunctival vascular disorder, conjunctival deposit, ocular hyperemia, conjunctivochalasis, conjunctivitis, ligneous conjunctivitis
Subtypes (3): conjunctival intraepithelial neoplasm, conjunctival cancer, benign conjunctival neoplasm
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 3.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 2 |
| PHASE1 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT00456495 | PHASE1 | COMPLETED | Effect of Ranibizumab on Malignant Conjunctival Neoplasia |
| NCT03515954 | Not specified | COMPLETED | AS-OCT Guided Treatment of Diffuse CSCC |
| NCT05645341 | Not specified | COMPLETED | Artificial Intelligence-assisted Screening of Malignant Pigmented Tumors on the Ocular Surface |
Drugs tested across these trials (top 30)
| Molecule | Max phase | Trials referencing |
|---|---|---|
| RANIBIZUMAB | 4 | 1 |
Related Atlas pages
- Drugs: Ranibizumab